Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Davì

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Microparticles in type 2 diabetes mellitusG Davì, P Ferroni
European Journal of Internal Medicine|May 25, 2010
Aspirin as antiplatelet agent in diabetes. PROS-G Davì, F Santilli
Journal of Thrombosis and Haemostasis : JTH|July 14, 2006
Unveiling the inflammatory face of antiplatelet drugsG Davì, F Santilli
Recenti Progressi in Medicina|February 2, 2002
[Prevention of venous thromboembolism: controversies on the table]S Fontana, G Davì
Cardiologia (Rome, Italy)|April 1, 1985
[Prostaglandins and ischemic cardiopathy]A Strano, G Davì
Lupus|October 13, 2005
Oxidant stress, inflammation and atherogenesisG Davì, A Falco
Advances in Experimental Medicine and Biology|January 1, 1984
Platelet function tests and coronary heart diseaseA Strano, G Davì
European Journal of Internal Medicine|June 27, 2016
Aspirin, platelets, and cancer: The point of view of the internistF Santilli, A Boccatonda, G Davì
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Thromboxane-dependent platelet activation as a transducer of enhanced risk of coronary and cerebral thrombosisC Patrono, G Ciabattoni, G Davì
Agents and Actions. Supplements|January 1, 1992
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factorsC Patrono, G Davì, G Ciabattoni
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Microparticles in type 2 diabetes mellitusG Davì, P Ferroni
European Journal of Internal Medicine|May 25, 2010
Aspirin as antiplatelet agent in diabetes. PROS-G Davì, F Santilli
Journal of Thrombosis and Haemostasis : JTH|July 14, 2006
Unveiling the inflammatory face of antiplatelet drugsG Davì, F Santilli
Recenti Progressi in Medicina|February 2, 2002
[Prevention of venous thromboembolism: controversies on the table]S Fontana, G Davì
Cardiologia (Rome, Italy)|April 1, 1985
[Prostaglandins and ischemic cardiopathy]A Strano, G Davì
Lupus|October 13, 2005
Oxidant stress, inflammation and atherogenesisG Davì, A Falco
Advances in Experimental Medicine and Biology|January 1, 1984
Platelet function tests and coronary heart diseaseA Strano, G Davì
European Journal of Internal Medicine|June 27, 2016
Aspirin, platelets, and cancer: The point of view of the internistF Santilli, A Boccatonda, G Davì
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Thromboxane-dependent platelet activation as a transducer of enhanced risk of coronary and cerebral thrombosisC Patrono, G Ciabattoni, G Davì
Agents and Actions. Supplements|January 1, 1992
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factorsC Patrono, G Davì, G Ciabattoni
Pageof 14